Search results
Eli Lilly and Company (NYSE:LLY) PT Raised to $957.00 at Jefferies Financial Group
ETF DAILY NEWS· 6 days agoEli Lilly and Company (NYSE:LLY – Get Free Report) had its price target upped by investment analysts at Jefferies Financial Group from $925.00 to $957.00 in a research report ...
Tony Awards 2024: Who Will Win vs. Who Should
The Wrap via Yahoo News· 4 hours agoSunday's ceremony will look to honor the stars, with expected wins for Alicia Keys, Sarah Paulson, Daniel Radcliffe and Jeremy Strong The post Tony...
Eli Lilly and Company (NYSE:LLY) Stock Price Up 0.8% Following Analyst Upgrade
ETF DAILY NEWS· 5 days agoEli Lilly and Company (NYSE:LLY – Get Free Report) rose 0.8% during trading on Monday after Jefferies Financial Group raised their price target on the stock from $925.00 to ...
Eli Lilly's Potential Alzheimer’s Drug Clears a Big Hurdle
Time via Yahoo News· 3 days agoA panel of brain and Alzheimer’s experts convened by the U.S. Food and Drug Administration (FDA)...
Eli Lilly exec expects obesity pill data in April 2025
WSAU Wausau· 4 days ago(Reuters) - Data from Eli Lilly's late stage trial on experimental obesity pill orforglipron is...
Rewriting my story with Eli’s help
The Lake County Record-Bee· 7 days agoOPINION- I’ve been working on a script with a producer named Eli.
Lilly Endowment Inc sells over $64 million in Eli Lilly stock By Investing.com
Investing.com· 3 days agoIn a recent transaction, Lilly Endowment Inc, a substantial shareholder in Eli Lilly & Co...
Eli Lilly Stock Reaches All-Time High: What’s Driving It Higher? | Bankrate
Bankrate.com· 2 days agoEli Lilly (LLY) is experiencing a banner year, as its stock price has reached new all-time highs in...
Zacks Market Edge Highlights: CAVA, Abercrombie & Fitch, Eli Lilly, CrowdStrike and Deckers Outdoor
Zacks via Yahoo Finance· 19 hours agoShares of Abercrombie & Fitch are up 118% year-to-date to new highs. But earnings are also expected...
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)
Zacks via Yahoo Finance· 12 hours agoIf Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by...